300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Paraguay
Moldova
Seychelles
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Centre for Cellular and Molecular Platforms, VC Fund

Centre for Cellular and Molecular Platforms

VC Fund

Bangalore, India

Centre for Cellular and Molecular Platforms is a VC fund in Bangalore focused on Health Care and Medical. The Centre for Cellular and Molecular Platforms, or C-CAMP an initiative supported by the Department of Biotechnology, Govt of India is an enabler or catalyst of cutting-edge research and innovation in the life sciences since 2009. C-CAMP is also a member of the Bangalore Life Science Cluster (BLiSC). We facilitate Bioscience Research andEntrepreneurship by providing Research, Development, Training, and Services in state-of-the-art Technology Platforms.

Total investments:
8
Last investment:
Lead investor:
13%

Last updated:

Industries Centre for Cellular and Molecular Platforms invests in

Health CareMedicalManufacturingMedical DeviceAgTech

Stages Centre for Cellular and Molecular Platforms invests in

SeedGrantPre-Seed

Countries Centre for Cellular and Molecular Platforms invests in

India

Round sizes

Seed $276k–$3M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$276k–$3M

Investment Focus

Industry

  • Health Care 4 (50%)
  • Medical 2 (25%)
  • Manufacturing 2 (25%)
  • Medical Device 2 (25%)
  • AgTech 1 (13%)
See all 16 industries →

Stage

  • Seed 6 (75%)
  • Grant 1 (13%)
  • Pre-Seed 1 (13%)

Team

NameTitleInvestmentsLinksEmail
Nitya Raman Sr program Manager
Sr program Manager Total investments: 1
Find email
Satyajit Mayor
Satyajit Mayor Co-Founder
Co-Founder Total investments: 0 Find email
Taslimarif Saiyed
Taslimarif Saiyed CEO and Director
CEO and Director Total investments: 0
Find email

Investments

CompanyDescriptionRoundLinks
CrisprBits is an Indian company using CRISPR, a breakthrough gene-editing technology, to develop high-quality solutions in the life sciences that all Indians can afford. $3M / Seed / Nov 25, 2025
Aikenist is a healthcare technology firm that offers artificial intelligence-based medical imaging solutions for quicker scanning, better detection, and faster turnaround. AIkenist creates products that improve the end-to-end patient experience and maximize the utilization of medical equipment. AIkenist incorporates artificial intelligencecapabilities to produce quicker scanning, superior picture quality, and a better patient experience. Their founding team has strong entrepreneurial, engineering, and academic credentials, as well as experience in top management, product, and engineering positions in AI, biomedical, and cloud organizations.Aikenist was founded in 2019 and is headquartered in Bangalore, Karnataka. Seed / Oct 01, 2024
Farmroot Agritech is an one-stop solution provider that helps farmers from seed to harvest and allied marketing services. Grant / Jan 30, 2024
Janitri develops sustainable technology to improve maternal and child healthcare. $1.1M / Seed / May 02, 2023
Fibroheal Woundcare uses the biomaterial property of silk and silk protein to provide wound care management for acute, chronic, surgical, and traumatic wounds. Its products include sheets, mesh, foams, powder, and particles. $275.6K / Seed / Nov 29, 2022
Yostra Labs Private Limited is a healthcare technology firm pioneering smart innovations to make healthcare more effective, affordable and sustainable for the cost sensitive developing market. We are committed to solve pertinent healthcare issues through innovative, practical, and cutting edge technology solutions. $505.4K / Seed / Aug 16, 2022
SiCureMi is a medical device manufacturing company that specializes in the fields of vital signs monitoring and decision support. It aims to develop an affordable and non-invasive intelligent self-care product for users providing personalized care using predictive analytics from historical/real-time data using IOT/Mobile based app. $425K / Pre-Seed / Sep 22, 2021
SiCureMi is a medical device manufacturing company that specializes in the fields of vital signs monitoring and decision support. It aims to develop an affordable and non-invasive intelligent self-care product for users providing personalized care using predictive analytics from historical/real-time data using IOT/Mobile based app. $750K / Seed / Sep 22, 2021

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Paraguay
Moldova
Seychelles
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Centre for Cellular and Molecular Platforms invest in?

Centre for Cellular and Molecular Platforms invests primarily in Health Care, Medical and Manufacturing startups, most often at Seed and Grant stage. Most of the 8 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Centre for Cellular and Molecular Platforms invest in?

Centre for Cellular and Molecular Platforms typically joins rounds of $276k–$3M at Seed. These are whole funding-round sizes, not Centre for Cellular and Molecular Platforms's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Centre for Cellular and Molecular Platforms took part in.

How do I contact Centre for Cellular and Molecular Platforms?

Public channels for Centre for Cellular and Molecular Platforms include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Centre for Cellular and Molecular Platforms?

The team at Centre for Cellular and Molecular Platforms includes Nitya Raman (Sr program Manager), Satyajit Mayor (Co-Founder) and Taslimarif Saiyed (CEO and Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Centre for Cellular and Molecular Platforms Centre for Cellular and Molecular Platforms Find emails